We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
-17.7%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$15.4B
AUM Growth
-$15B
(-49%)
Cap. Flow
-$10.3B
Cap. Flow
% of AUM
-67%
Top 10 Holdings %
Top 10 Hldgs %
16.78%
Holding
2,035
New
220
Increased
323
Reduced
965
Closed
455
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$292M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$99M |
| 3 |
Apple
AAPL
|
+$97.9M |
| 4 |
Goldman Sachs
GS
|
+$87.8M |
| 5 |
Merck
MRK
|
+$81.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$132M |
| 2 |
Nike
NKE
|
+$128M |
| 3 |
Lam Research
LRCX
|
+$126M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$125M |
| 5 |
Procter & Gamble
PG
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Healthcare | 15.9% |
| 3 | Financials | 13.31% |
| 4 | Consumer Discretionary | 13.02% |
| 5 | Consumer Staples | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
301
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.97M | 0.06% |
89,191
-195,791
| -69% | -$20.3M |
|
302
Corcept Therapeutics
CORT
$10.2B
| $8.94M | 0.06% |
751,707
+155,912
| +26% | +$1.93M |
|
303
Globe Life
GL
$13.5B
| $8.82M | 0.06% |
122,532
-29,263
| -19% | -$2.76M |
|
304
Ameren
AEE
$31.5B
| $8.8M | 0.06% |
120,876
-52,412
| -30% | -$4.16M |
|
305
Genpact
G
$5.3B
| $8.72M | 0.06% |
298,701
-258,228
| -46% | -$10.1M |
|
306
Keurig Dr Pepper
KDP
$40.4B
| $8.69M | 0.06% |
357,895
-405,598
| -53% | -$10.9M |
|
307
Colgate-Palmolive
CL
$72.6B
| $8.64M | 0.06% |
130,262
-26,144
| -17% | -$1.84M |
|
|
CYOU
308
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $8.64M | 0.06% |
807,468
-253,080
| -24% | -$2.67M |
|
309
AerCap
AER
$23.9B
| $8.64M | 0.06% |
379,080
-619,910
| -62% | -$30.6M |
|
310
Williams Companies
WMB
$90.5B
| $8.6M | 0.06% |
608,042
-157,558
| -21% | -$3.05M |
|
311
Kimberly-Clark
KMB
$36.4B
| $8.59M | 0.06% |
67,139
-90,432
| -57% | -$12.5M |
|
312
Exelixis
EXEL
$13.9B
| $8.5M | 0.06% |
493,534
-157,019
| -24% | -$2.87M |
|
313
Usana Health Sciences
USNA
$394M
| $8.46M | 0.05% |
146,428
-29,472
| -17% | -$2.05M |
|
|
VGR
314
DELISTED
Vector Group Ltd.
VGR
| $8.42M | 0.05% |
1,259,803
-823,871
| -40% | -$7.26M |
|
|
EGOV
315
DELISTED
NIC Inc
EGOV
| $8.34M | 0.05% |
362,525
-235,317
| -39% | -$4.8M |
|
316
Cognizant
CTSH
$21.5B
| $8.32M | 0.05% |
178,957
-2,116
| -1% | -$126K |
|
|
MXIM
317
DELISTED
Maxim Integrated Products
MXIM
| $8.3M | 0.05% |
170,851
-563,237
| -77% | -$32.3M |
|
318
Portland General Electric
POR
$6.02B
| $8.3M | 0.05% |
173,042
-213,300
| -55% | -$12M |
|
319
Rockwell Automation
ROK
$51.4B
| $8.24M | 0.05% |
54,607
-143,221
| -72% | -$26.5M |
|
320
Haemonetics
HAE
$3.58B
| $8.19M | 0.05% |
82,211
-475
| -0.6% | -$51.5K |
|
321
Illumina
ILMN
$29.4B
| $8.12M | 0.05% |
30,548
-31,972
| -51% | -$8.94M |
|
322
Pacira BioSciences
PCRX
$1.02B
| $8.04M | 0.05% |
239,883
+156,663
| +188% | +$6.51M |
|
323
Ironwood Pharmaceuticals
IRWD
$611M
| $7.99M | 0.05% |
791,863
+621,395
| +365% | +$7.3M |
|
324
Kinross Gold
KGC
$28.5B
| $7.97M | 0.05% |
2,002,853
+1,121,753
| +127% | +$5.43M |
|
325
Skyworks Solutions
SWKS
$9.06B
| $7.96M | 0.05% |
89,020
-174,549
| -66% | -$18.6M |
|
Similar funds
Man Group's Q1 2020 Portfolio in Review
As of Q1 2020, Man Group held 2,035 positions worth $15.4B, down 49% from $30.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group withdrew a net $10.3B in Q1 2020, closing 455 positions and reducing 965 holdings. Its most notable exit was Allergan plc, an estimated $65.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Man Group opened a new position in Enbridge worth $17.8M.
- Man Group's largest Q1 2020 buy was Enbridge: 618,403 shares worth $17.8M.
- Man Group added most to Amazon in Q1 2020, an estimated $292M increase.
- Man Group's biggest Q1 2020 reduction was Starbucks, cutting an estimated $132M.
- Man Group fully exited Allergan plc in Q1 2020, selling an estimated $65.8M.
- Man Group's ten largest holdings make up 17% of its $15.4B portfolio in Q1 2020.
- Man Group opened 220 new positions and closed 455 in Q1 2020.
- Man Group's portfolio value fell 49% quarter-over-quarter to $15.4B.
Based on Man Group's 13F filing for Q1 2020, filed 15 May 2020.